Ultrasound-guided pain relief for heart procedures
Analgesic Effect of Ultrasound-Guided Transversus Abdominis Plan (TAP) Block in Femoral Endovascular Cardiac Interventions: A Prospective-randomized Study
NA · Istanbul University - Cerrahpasa · NCT06576128
This study is testing if using ultrasound to guide a specific pain relief technique can make heart procedures more comfortable for patients.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 100 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Istanbul University - Cerrahpasa (other) |
| Locations | 1 site (Istanbul) |
| Trial ID | NCT06576128 on ClinicalTrials.gov |
What this trial studies
This study investigates the use of ultrasound-guided transversus abdominis plane (TAP) block to provide analgesia during endovascular cardiac interventions such as coronary angiography and cardiac catheterization. By targeting specific nerve branches that innervate the femoral region, the study aims to enhance patient comfort and satisfaction during these procedures. The study will assess both patient and physician satisfaction levels, contributing to a better understanding of pain management in cardiac interventions.
Who should consider this trial
Good fit: Ideal candidates are adults over 18 years undergoing elective coronary angiography, cardiac catheterization, or percutaneous coronary intervention.
Not a fit: Patients under 18, those requiring emergency procedures, or individuals with certain medical conditions may not benefit from this study.
Why it matters
Potential benefit: If successful, this approach could significantly improve pain management and patient satisfaction during cardiac procedures.
How similar studies have performed: While the use of TAP blocks in other surgical fields has shown promise, this specific application in cardiac interventions is relatively novel.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * The patient is over 18 years of age * Coronary angiography, cardiac catheterization and percutaneous coronary intervention will be applied to the patient, * The above-mentioned procedures will be taken under elective conditions, * Providing an optimal image when imaging the patient with ultrasound, * INR\< 1.5 * If the patient gives consent, S/he will be included in the study. Exclusion Criteria: * Patients under 18 years of age, * Patients treated under emergency conditions, * morbid obesity (BMI\>35 kg/m2), * pregnant women, * New York Heart Association (NYHA) stage 4 patients with advanced decompensated heart failure, * Patients with symptoms such as redness, temperature increase, infection, hematoma in the application area before the procedure, * Patients with a history of allergy to local anesthetics, * Patients who cannot be communicated, * Those with severe psychosis or progressive neurological deficits and muscle disease, * Patients who do not consent to the application will be excluded from the study.
Where this trial is running
Istanbul
- Istanbul University- Cerrahpasa — Istanbul, Turkey (Türkiye) (RECRUITING)
Study contacts
- Study coordinator: Gozde Altun
- Email: gozde.altun@iuc.edu.tr
- Phone: +905544290333
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Anesthesiology, Percutaneous Coronary Intervention, Cardiac Catheterization, Analgesia, Satisfaction, Patient, ultrasonography, anesthesiology, transversus abdominis plane block